Log in

NASDAQ:APLTApplied Therapeutics Stock Price, Forecast & News

$30.47
-0.75 (-2.40 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$30.14
Now: $30.47
$31.29
50-Day Range
$32.35
MA: $41.79
$51.23
52-Week Range
$8.09
Now: $30.47
$57.39
Volume169,200 shs
Average Volume308,878 shs
Market Capitalization$674.30 million
P/E RatioN/A
Dividend YieldN/A
Beta1.19
Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy. The company's preclinical stage products include AT-001 for acute myocardial infraction; AT-007 for treating galactosemia; AT-003 to treat diabetic retinopathy; and AT-104 for the treatment of orphan hematological oncology. Applied Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.38 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:APLT
CUSIPN/A
CIKN/A
Phone212-220-9226

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees4
Market Cap$674.30 million
Next Earnings Date8/10/2020 (Estimated)
OptionableNot Optionable

Receive APLT News and Ratings via Email

Sign-up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter.

Applied Therapeutics (NASDAQ:APLT) Frequently Asked Questions

How has Applied Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Applied Therapeutics' stock was trading at $29.59 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, APLT shares have increased by 3.0% and is now trading at $30.47. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Applied Therapeutics?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied Therapeutics in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Applied Therapeutics.

When is Applied Therapeutics' next earnings date?

Applied Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for Applied Therapeutics.

How were Applied Therapeutics' earnings last quarter?

Applied Therapeutics (NASDAQ:APLT) released its quarterly earnings results on Monday, May, 11th. The company reported ($0.59) earnings per share for the quarter, topping the consensus estimate of ($0.82) by $0.23. View Applied Therapeutics' earnings history.

What price target have analysts set for APLT?

6 equities research analysts have issued twelve-month price objectives for Applied Therapeutics' shares. Their forecasts range from $43.00 to $65.00. On average, they anticipate Applied Therapeutics' share price to reach $55.20 in the next twelve months. This suggests a possible upside of 81.2% from the stock's current price. View analysts' price targets for Applied Therapeutics.

Has Applied Therapeutics been receiving favorable news coverage?

News articles about APLT stock have been trending very negative recently, according to InfoTrie. The research group rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Applied Therapeutics earned a media sentiment score of -3.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Applied Therapeutics.

Are investors shorting Applied Therapeutics?

Applied Therapeutics saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 802,800 shares, an increase of 11.7% from the June 15th total of 718,400 shares. Based on an average daily volume of 181,900 shares, the short-interest ratio is currently 4.4 days. Approximately 6.3% of the company's stock are sold short. View Applied Therapeutics' Current Options Chain.

Who are some of Applied Therapeutics' key competitors?

What other stocks do shareholders of Applied Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied Therapeutics investors own include Vertex Pharmaceuticals (VRTX), Alteryx (AYX), Enterprise Products Partners (EPD), Adobe (ADBE), Medtronic (MDT), Pfizer (PFE), Verizon Communications (VZ), Advanced Micro Devices (AMD), IBM (IBM) and Netflix (NFLX).

Who are Applied Therapeutics' key executives?

Applied Therapeutics' management team includes the following people:
  • Dr. Shoshana Shendelman Ph.D., Chairman, Founder, Pres, CEO & Sec. (Age 40)
  • Dr. Mark Joseph Vignola, Chief Financial Officer (Age 42)
  • Dr. Riccardo Perfetti, Chief Medical Officer (Age 59)

When did Applied Therapeutics IPO?

(APLT) raised $60 million in an initial public offering on the week of May 13th 2019. The company issued 4,000,000 shares at $14.00-$16.00 per share. Citigroup, Cowen and UBS Investment Bank served as the underwriters for the IPO and Baird was co-manager.

What is Applied Therapeutics' stock symbol?

Applied Therapeutics trades on the NASDAQ under the ticker symbol "APLT."

How do I buy shares of Applied Therapeutics?

Shares of APLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Applied Therapeutics' stock price today?

One share of APLT stock can currently be purchased for approximately $30.47.

How big of a company is Applied Therapeutics?

Applied Therapeutics has a market capitalization of $674.30 million. Applied Therapeutics employs 4 workers across the globe.

What is Applied Therapeutics' official website?

The official website for Applied Therapeutics is www.appliedtherapeutics.com.

How can I contact Applied Therapeutics?

Applied Therapeutics' mailing address is 340 MADISON AVENUE 19TH FLOOR, NEW YORK NY, 10173. The company can be reached via phone at 212-220-9226 or via email at [email protected]

This page was last updated on 7/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.